DENTSPLY SIRONA: 10% Upside Ripe for the Taking in Health Care
By stockpickr AI | March 1, 2026 | 10 min read
Investment Summary
DENTSPLY SIRONA (Health Care) appears slightly undervalued based on the DCF analysis, suggesting potential upside relative to its current market price.
Investment Recommendation
Buy
Fair Value: $35.45
Current Price: $32.01
Upside/Downside: +10.75%
The DCF analysis suggests an implied fair value slightly higher than the current trading price of $32.01, indicating moderate undervaluation. The primary driver for this valuation is the stable terminal growth rate assumption reflecting mature market penetration in global dental care.
Key Metrics
- Market Cap: $5.42B
- P/E Ratio: 18.89x
- Forward P/E: 17.55x
- Revenue Growth (YoY): 1.80%
- Net Margin: 10.05%
- ROE: 14.18%
- Debt/Equity: 0.79
- Dividend Yield: 1.41%
Strengths
- Strong market presence in dental equipment and consumables, providing diversified revenue streams.
- Net Margin of 10.05% in the last fiscal year, indicating solid profitability management.
- ROE of 14.18%, showing efficient use of shareholder equity to generate profits.
- Steady backlog of recurring revenue from high-margin consumable products.
Risk Factors
- High debt-to-equity ratio (0.79) indicating greater financial leverage compared to some peers.
- Sensitivity to discretionary spending on dental equipment and procedures, making it susceptible to economic downturns.
- Intense competition from both established medical device companies and emerging digital dentistry pure plays.